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Brown algae such as Ascophyllum  nodosum  and Lam inaria  
digitata  have the ability to accumulate halogens like Br and I 
from  seawater to an amazing extent. Haloperoxidases, enzymes 
that incorporate halide ions into organic substrates with H2O2 as a 
coreactant, are essential for the m ediation o f halogen uptake,1 and 
are involved in the biosynthesis o f various halogenated natural 
products.2 They contain a V cofactor in the form of vanadate3 
which appears to interact with H2O 2 only, not with Br- or the 
organic substrate.4 The absence of coordination o f Br" to V is well 
established by X-ray absorption spectroscopy (XAS) at the 
vanadium  K edge.5 In Br K edge extended X-ray absorption fine 
structure (EXAFS) studies6 where Ascophyllum  nodosum  
brom operoxidase (AnvBPO) was titrated with Br" in the absence 
o f H2O2, it was reported that Br is incorporated in the enzyme by 
formation of a covalent bond. This Br was proposed to be bound 
to an amino acid in the active site, viz. a Ser residue which is H- 
bonded to the vanadate, with implications for the catalytic cycle. 
W e have recently interpreted the EXAFS of a num ber o f relevant 
I and Br reference com pounds,7 and demonstrated that it is 
possible to distinguish the bond lengths between halogens and 
sp2- and sp3-hybridized carbons. This prompted us to investigate 
the proposed reactive B r interm ediate in A n vBPO in more detail.
Our experimental approach initially followed that described in 
the literature5 in which XAS spectra at the Br K edge were taken 
o f A n vBPO in the presence o f varying amounts o f Br-, up to 1 
m olar equivalent. W e hardly detected EXAFS contributions 
characteristic6,7 o f non-covalently bound, hydrated Br- in our 
titration.8 The Fourier transform  (FT) showed significant peaks up 
till approx. 6 A, which is exceptional for biological EXAFS. The 
pattern o f peaks reminded us o f that characteristic o f a phenyl ring 
which is meta-disubstituted with halogens,7 and indeed a good 
m atch was found with the spectrum of 3,5-dibrom otyrosine 
(Br2Tyr). It is unlikely that the enzyme would be able to use the 
B r- added in the titration to incorporate it into its aromatic groups 
in the absence o f H2O2. W e therefore hypothesized that the Br 
was already incorporated in the aromatic groups in the enzyme at 
the start o f our titration, to such an extent that its EXAFS signal 
dom inated that o f the Br- that had been added in near-equivalent 
amounts. This hypothesis was confirmed by the result o f a blank 
experiment in which the Br EXAFS o f A n vBPO was measured in 
the absence o f added Br-; the agreement with the results for 
B r2Tyr and the mixed halogen aromatic reference compound 3- 
brom o-5-iodobenzoic acid (BrIBA) is excellent (Fig. 1).
The enzyme has probably had opportunities to react with both 
B r- and H 2O2, either during its translation and folding or under 
physiological circumstances in the alga. It is also possible that the 
enzyme was halogenated during extraction and purification. If Br
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F igure  1. Experimental (solid) and simulated (dashed, parameters in 
Chart 1) Br K EXAFS (top panel) and phase-corrected FT (bottom panel) 
of (top to bottom) Br2Tyr in BN (raw data), 1.3 mM AnvBPO in 50 mM 
Tris-HCl, pH 9.0, and BrIBA in aqueous 1 M KOH (Fourier-filtered 0.8­
7.0 A).
appears to be incorporated on Tyr residues o f the enzyme, there 
may have been opportunities for I to be incorporated as well. 
Prelim inary XAS experiments at the iodine L3 edge revealed that 
the native enzyme indeed contains I.8 Guided by the results for 
our reference compounds (Fig. 1) we undertook simulations o f the 
A n vBPO Br EXAFS to determine whether the other halogen atom 
in the brom inated aromatic ring was Br or I. Following an 
approach described in detail elsewhere,7 the EXAFS spectra were 
simulated with the programme EXCURV E,9 using distances 
derived from the crystal structure10 of the methoxy analogue of 
B r2Tyr as restraints11 for the ring atoms in  the refinement. The 
results o f the refined simulations (dashed lines in Fig. 1,
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Table 1. M S/M S analyses o f the 438-454 residues tryptic peptides 
from A n vBPO
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C hart 1. Distances (A) to the Br absorber atom found in the refined 
simulations for the spectra in Fig.1. Left, Br2Tyr; middle, native AnvBPO; 
right, BrIBA. Atoms in parentheses were not included in the simulation. 
Debye-Waller-type factors as 2 a 2 (A2) in parentheses. Errors for 1st-shell 
distances 0.02 A, other distances 0.05 A.
geometries in Chart 1) for the B r2Tyr EXAFS are consistent with 
those of the crystal structure,10 including the Br-Br distance 
(5.664 A vs. 5.672 A), while the Br-I distance in BrIBA was 
somewhat longer (5.845 A), in line with the larger atomic radius 
o f  I. For A n vBPO the best fit (Fig. 1) was with Br in the meta­
position and an optim um  occupancy of 90 % o f that o f the ring 
atoms. M ixtures o f Br and I in ratios between 1:1 and 2:1 also 
gave reasonable fits8 (fit index 0.4034) but not as good as Br 
alone (0.3266).
ESI-Q-TOF mass spectrometry (MS) analyses were performed 
on trypsin-digested A n vBPO, in order to determine which and 
how many amino acids were halogenated. M any observed 
peptides correspond with a good accuracy to the predicted ones 
and cover 63% o f the protein sequence. However, only one of 
them  appears to contain 2 Br as indicated by the addition of 157.8 
D a (Table 1) to the second Tyr, Y447, in the corresponding 
M S/M S spectra;8 both the non-halogenated and the doubly 
brom inated peptides are observed, but no mono-brominated or 
iodinated peptides.
Interestingly, the crystal structure o f  A n vB PO 12 reveals the 
presence o f two iodinated Tyr residues at the surface o f each of 
both monomers, Y447 and Y398. The choice o f I to fit the 
residual electron density in the crystal structure determination 
appears to be rather arbitrary, and it was proposed that the crystal 
contains different conformers o f a m ono-iodinated Tyr. However, 
the modeling o f I atoms is problematic, since it results in strong 
negative peaks in the Fo-Fc electron density map, even with a 
partial occupancy of 0.5. Therefore, the compatibility o f 
brom ination of these tyrosines in the crystal structure was tested 
by reconducting structural refinement with REFM A C13 (version 
5). To this purpose, the coordinates and structure factors o f 
A nvBPO12 (id codes 1QI9 and r1qi9sf) were submitted to 
refinement replacing the iodinated Tyr by Br2Tyr (using distances 
obtained by EXAFS, see below). Clearly, the structural model 
assum ing B r2Tyr as residue 447 in both m onomers and a 3- 
m onobrominated Tyr as residue 398 o f monomer A is in better 
agreement with the experimental crystallographic data.8 This is 
demonstrated by the lower Rfree value obtained (18.5%) after one 
refinement cycle. However, the occupancy o f the Br positions is 
not 100%. The best R (15.3%) and Rfree (18.5%) values were 
obtained with 70% 3-bromo- and 55% 5-brom otyrosines at 
position 447, and the results were identical for the two monomers. 
In comparison, the R values for the deposited structure were 
16.5% (R) and 21.9% (Rfree), respectively.12 At these occupancy 
values, negative peaks alm ost disappeared from the Fo-Fc electron 
density m ap.8 The occupancy o f the B r position in Y398 remains 
very low (~20%), in agreement with MS analyses, where no 
halogenation o f this Tyr was detected.
In conclusion, using a combination of experiments (EXAFS, 
M S/M S of tryptic digests) and modeling (structure refinement)
M H+(obs.) MH+(calc.) A M P eptide sequence
Da Da D a
1881.86 1881.77 0.09 GGDCYPDPVYPDDDGLK
2039.67 2039.57 0.10 GGDCYPDPVXPDDDGLK
X = Br2Tyr
we find that native AnvBPO contains Br in  the surface Tyr 
residues 447 (frequently di-brominated) and 398 (rarely mono- 
brom inated). These brom inated Tyr residues are not likely to be 
reactive interm ediates in the catalytic cycle o f AnvBPO due to 
their location at the surface and the nature o f the Br-Tyr bond. I 
XAS reveals I incorporation to a lower extent, which is not 
detectable by M S/M S. Our results are an im portant correction to 
the iodinated Tyr and reactive brom inated Ser residues that were 
proposed in earlier crystallographic12 and spectroscopic6 studies, 
respectively. The reactive role o f this Ser residue in haloperoxida- 
ses was already controversial because o f lack of both solvent ac- 
cessibility14 and an effect o f mutation to Ala.15 In future work, we 
will address the questions o f the origin o f this posttranslational 
m odification in AnVBPO, o f possible differences in  enzymatic ef­
ficiency between halogenated and non-halogenated AnvBPO, and 
o f the halogenation o f algal vanadium haloperoxidases in general.
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Abstract:
Based on EXAFS and MS/MS experimental results and a reinterpretation of the electron density map 
obtained by X-ray crystallography, we describe a new post-translational modification, viz. a 3,5- 
dibromotyrosine residue that is incorporated in the polypeptide chain of a vanadium haloperoxidase.
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